Suppr超能文献

人肺和脑微血管内皮细胞的止血特性。

Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells.

作者信息

Grau G E, de Moerloose P, Bulla O, Lou J, Lei Z, Reber G, Mili N, Ricou B, Morel D R, Suter P M

机构信息

Department of Anaesthesiology, University Hospital, Geneva, Switzerland.

出版信息

Thromb Haemost. 1997 Mar;77(3):585-90.

PMID:9066014
Abstract

Little is known on the haemostatic profiles of human microvascular endothelial cells (MVEC) from different tissues. In addition it is not known whether MVEC from patients display the same haemostatic pattern as MVEC coming from healthy controls. To address these questions MVEC from human lung and brain were isolated and stimulated with tumour necrosis factor alpha (TNF) and E. coli lipopolysaccharide (LPS) for 24 h. The level and the kinetics of procoagulant activity (PCA) and thrombomodulin (TM) expression were found to be different depending on the tissue of origin and on the agonist used. In particular, the inducible PCA was higher in lung than in brain MVEC, an observation that may be related to the frequency of lung involvement in septic shock. Differences were also observed for tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) with MVEC supernatants or cell lysates. These variables were then measured in lung MVEC purified from patients with acute respiratory distress syndrome (ARDS) and compared to controls. Cells from ARDS patients constitutively expressed more PCA and PAI-1 than controls. The fibrinolytic potential, expressed as t-PA/PAI-1 ratio, was lower in ARDS than in lung MVEC. It is concluded that MVEC display different haemostatic features depending on the tissue they come from and that lung MVEC from ARDS patients present a procoagulant profile when compared with those from controls.

摘要

关于来自不同组织的人微血管内皮细胞(MVEC)的止血特征,人们了解甚少。此外,尚不清楚患者的MVEC是否与健康对照者的MVEC表现出相同的止血模式。为了解决这些问题,分离了来自人肺和脑的MVEC,并用肿瘤坏死因子α(TNF)和大肠杆菌脂多糖(LPS)刺激24小时。发现促凝血活性(PCA)和血栓调节蛋白(TM)表达的水平及动力学因起源组织和所用激动剂的不同而有所差异。特别是,诱导型PCA在肺MVEC中高于脑MVEC,这一观察结果可能与脓毒症休克中肺部受累的频率有关。在MVEC上清液或细胞裂解物中,组织纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂1(PAI-1)也观察到差异。然后在从急性呼吸窘迫综合征(ARDS)患者中纯化的肺MVEC中测量这些变量,并与对照进行比较。ARDS患者的细胞组成性表达的PCA和PAI-1比对照更多。以t-PA/PAI-1比值表示的纤溶潜力在ARDS中低于肺MVEC。结论是,MVEC根据其来源组织表现出不同的止血特征,并且与对照相比,ARDS患者的肺MVEC呈现促凝血特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验